Praxis Precision Medicines Inc (NASDAQ: PRAX) kicked off on Monday, up 6.88% from the previous trading day, before settling in for the closing price of $173.97. Over the past 52 weeks, PRAX has traded in a range of $26.70-$205.89.
During the last 5-year period, the sales growth of Healthcare Sector giant was 8.54%. While this was happening, its average annual earnings per share was recorded -31.92%. With a float of $22.77 million, this company’s outstanding shares have now reached $24.19 million.
Praxis Precision Medicines Inc (PRAX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Praxis Precision Medicines Inc is 5.88%, while institutional ownership is 97.83%. The most recent insider transaction that took place on Nov 14 ’24, was worth 660,827. In this transaction General Counsel and Secretary of this company sold 8,239 shares at a rate of $80.20, taking the stock ownership to the 10,301 shares. Before that another transaction happened on Nov 14 ’24, when Company’s Principal Accounting Officer sold 5,188 for $81.78, making the entire transaction worth $424,318. This insider now owns 5,613 shares in total.
Praxis Precision Medicines Inc (PRAX) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -2.75 earnings per share (EPS), lower than consensus estimate (set at -1.95) by -0.8. Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -31.92% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.11% during the next five years compared to 8.54% growth over the previous five years of trading.
Praxis Precision Medicines Inc (NASDAQ: PRAX) Trading Performance Indicators
Take a look at Praxis Precision Medicines Inc’s (PRAX) current performance indicators. Last quarter, stock had a quick ratio of 6.31. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 579.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -12.29, a number that is poised to hit -3.47 in the next quarter and is forecasted to reach -12.91 in one year’s time.
Technical Analysis of Praxis Precision Medicines Inc (PRAX)
Looking closely at Praxis Precision Medicines Inc (NASDAQ: PRAX), its last 5-days average volume was 0.87 million, which is a jump from its year-to-date volume of 0.55 million. As of the previous 9 days, the stock’s Stochastic %D was 82.83%.
During the past 100 days, Praxis Precision Medicines Inc’s (PRAX) raw stochastic average was set at 88.17%, which indicates a significant increase from 87.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 13.36 in the past 14 days, which was higher than the 4.41 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $68.90, while its 200-day Moving Average is $54.26. However, in the short run, Praxis Precision Medicines Inc’s stock first resistance to watch stands at $190.92. Second resistance stands at $195.91. The third major resistance level sits at $204.09. If the price goes on to break the first support level at $177.75, it is likely to go to the next support level at $169.57. Should the price break the second support level, the third support level stands at $164.58.
Praxis Precision Medicines Inc (NASDAQ: PRAX) Key Stats
The company with the Market Capitalisation of 4.50 billion has total of 21,166K Shares Outstanding. Its annual sales at the moment are 8,550 K in contrast with the sum of -182,820 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -69,300 K.
